Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relaxin’ the brain: a case for targeting the nucleus incertus network and relaxin‐3/RXFP3 system in neuropsychiatric disorders
Jigna Rajesh Kumar, Ramamoorthy Rajkumar, Tharindunee Jayakody, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 10, pp. 1061-1076
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

The Corticotropin-Releasing Factor Family: Physiology of the Stress Response
Jan M. Deussing, Alon Chen
Physiological Reviews (2018) Vol. 98, Iss. 4, pp. 2225-2286
Open Access | Times Cited: 220
Distribution, physiology and pharmacology of relaxin‐3/RXFP3 systems in brain
Sherie Ma, Craig M. Smith, Anna Błasiak, et al.
British Journal of Pharmacology (2016) Vol. 174, Iss. 10, pp. 1034-1048
Open Access | Times Cited: 77
Early-life adversity alters adult nucleus incertus neurons: implications for neuronal mechanisms of increased stress and compulsive behavior vulnerability
Anna Guguła, Patryk Sambak, Aleksandra Trenk, et al.
Neuropsychopharmacology (2025)
Open Access
Development of Diphenyl-1,2,4-Oxadiazole Analogues as Allosteric Modulators of the RXFP3 Receptor: Evaluation of Importance of the N-Substituted-2-Pyrrolidone Moiety in RLX-33
Dongliang Guan, Hetti Handi Chaminda Lakmal, Brooke N. Bender, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
The relaxin receptor as a therapeutic target – perspectives from evolution and drug targeting
Ross A. D. Bathgate, Martina Kočan, Daniel J. Scott, et al.
Pharmacology & Therapeutics (2018) Vol. 187, pp. 114-132
Open Access | Times Cited: 44
RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior
Alan Kania, Agata Szlaga, Patryk Sambak, et al.
Journal of Neuroscience (2020) Vol. 40, Iss. 28, pp. 5362-5375
Open Access | Times Cited: 29
Neuropeptides and small-molecule amine transmitters: cooperative signaling in the nervous system
Lee E. Eiden, Vito S. Hernández, Sunny Zhihong Jiang, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 9
Open Access | Times Cited: 18
Peptide-Based Drug Development
William D. Lubell
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2037-2037
Open Access | Times Cited: 16
Mechanisms of biased agonism by Gα i/o -biased stapled peptide agonists of the relaxin-3 receptor
Tharindunee Jayakody, Asuka Inoue, Srinivasaraghavan Kannan, et al.
Science Signaling (2024) Vol. 17, Iss. 823
Closed Access | Times Cited: 3
Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays
Hongkang Wu, Bradley L. Hoare, Thomas N. G. Handley, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116238-116238
Closed Access | Times Cited: 3
Differential effects of relaxin-3 and a selective relaxin-3 receptor agonist on food and water intake and hypothalamic neuronal activity in rats
Camila de Ávila, Sandrine Chometton, Christophe Lenglos, et al.
Behavioural Brain Research (2017) Vol. 336, pp. 135-144
Open Access | Times Cited: 29
The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease
Hanne Leysen, Deborah Walter, Lore Clauwaert, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4387-4387
Open Access | Times Cited: 15
Modulation of forebrain function by nucleus incertus and relaxin‐3/RXFP3 signaling
Francisco E. Olucha‐Bordonau, Héctor Albert‐Gascó, Francisco Ros‐Bernal, et al.
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 8, pp. 694-702
Open Access | Times Cited: 26
Discovery of a small molecule RXFP3/4 agonist that increases food intake in rats upon acute central administration
Brian A. DeChristopher, Soo-Hee Park, Linh Vong, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 8, pp. 991-994
Closed Access | Times Cited: 24
Unveiling a novel memory center in human brain: neurochemical identification of the nucleus incertus, a key pontine locus implicated in stress and neuropathology
Camila de Ávila, Anna Guguła, Aleksandra Trenk, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 2
Septal GABA and Glutamate Neurons Express RXFP3 mRNA and Depletion of Septal RXFP3 Impaired Spatial Search Strategy and Long-Term Reference Memory in Adult Mice
Mouna Haidar, Kimberly Tin, Cary Zhang, et al.
Frontiers in Neuroanatomy (2019) Vol. 13
Open Access | Times Cited: 22
Involvement of the Nucleus Incertus and Relaxin-3/RXFP3 Signaling System in Explicit and Implicit Memory
Isis Gil‐Miravet, Aroa Mañas-Ojeda, Francisco Ros‐Bernal, et al.
Frontiers in Neuroanatomy (2021) Vol. 15
Open Access | Times Cited: 17
Reproduction-Associated Hormones and Adult Hippocampal Neurogenesis
Lily Wan, Roujie Huang, Zhaohui Luo, et al.
Neural Plasticity (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 17
History of key regulatory peptide systems and perspectives for future research
Duan Chen, Jens F. Rehfeld, Alan G. Watts, et al.
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 11
Open Access | Times Cited: 6
Melanin-concentrating hormone and orexin systems in rat nucleus incertus: Dual innervation, bidirectional effects on neuron activity, and differential influences on arousal and feeding
Azadeh Sabetghadam, Agnieszka Grabowiecka-Nowak, Alan Kania, et al.
Neuropharmacology (2018) Vol. 139, pp. 238-256
Closed Access | Times Cited: 19
Intranasal administration of a stapled relaxin‐3 mimetic has anxiolytic‐ and antidepressant‐like activity in rats
Subhi Marwari, Anders Poulsen, Norrapat Shih, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 20, pp. 3899-3923
Open Access | Times Cited: 18
Recent progress in the understanding of relaxin family peptides and their receptors
Roger J. Summers
British Journal of Pharmacology (2017) Vol. 174, Iss. 10, pp. 915-920
Open Access | Times Cited: 15
Effects of chronic silencing of relaxin-3 production in nucleus incertus neurons on food intake, body weight, anxiety-like behaviour and limbic brain activity in female rats
Camila de Ávila, Sandrine Chometton, Sherie Ma, et al.
Psychopharmacology (2020) Vol. 237, Iss. 4, pp. 1091-1106
Closed Access | Times Cited: 13
Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades
Md Toufiqur Rahman, Hetti Handi Chaminda Lakmal, Javeena Hussain, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 1-2, pp. 71-81
Closed Access | Times Cited: 1
Brain RFamide Neuropeptides in Stress-Related Psychopathologies
Anita Kovács, Evelin Szabó, Kristóf László, et al.
Cells (2024) Vol. 13, Iss. 13, pp. 1097-1097
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top